303 related articles for article (PubMed ID: 15892894)
1. Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome.
Vitale C; Mercuro G; Castiglioni C; Cornoldi A; Tulli A; Fini M; Volterrani M; Rosano GM
Cardiovasc Diabetol; 2005 May; 4():6. PubMed ID: 15892894
[TBL] [Abstract][Full Text] [Related]
2. Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome.
Bahadir O; Uzunlulu M; Oguz A; Bahadir MA
Hypertens Res; 2007 Jan; 30(1):49-53. PubMed ID: 17460371
[TBL] [Abstract][Full Text] [Related]
3. Comparison of therapies between fixed-dose telmisartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild to moderate hypertension.
Minami J; Furukata S; Ishimitsu T; Matsuoka H
Int Heart J; 2009 Jan; 50(1):85-93. PubMed ID: 19246849
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus.
Derosa G; Querci F; Franzetti I; Dario Ragonesi P; D'Angelo A; Maffioli P
Hypertens Res; 2015 Oct; 38(10):690-4. PubMed ID: 25994603
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan Improves Insulin Resistance: A Meta-Analysis.
Wang Y; Qiao S; Han DW; Rong XR; Wang YX; Xue JJ; Yang J
Am J Ther; 2018; 25(6):e642-e651. PubMed ID: 29557807
[TBL] [Abstract][Full Text] [Related]
6. Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
Rizos CV; Milionis HJ; Kostapanos MS; Florentin M; Kostara CE; Elisaf MS; Liberopoulos EN
Clin Ther; 2010 Mar; 32(3):492-505. PubMed ID: 20399986
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.
Derosa G; Cicero AF; Bertone G; Piccinni MN; Fogari E; Ciccarelli L; Fogari R
Clin Ther; 2004 Aug; 26(8):1228-36. PubMed ID: 15476904
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of telmisartan and valsartan on insulin resistance in hypertensive patients with metabolic syndrome.
Ichikawa Y
Intern Med; 2007; 46(17):1331-6. PubMed ID: 17827829
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Tolerability of Olmesartan, Telmisartan, and Losartan in Patients of Stage I Hypertension: A Randomized, Open-label Study.
Kalikar M; Nivangune KS; Dakhale GN; Bajait CS; Sontakke SD; Motghare VM; Budania R
J Pharmacol Pharmacother; 2017; 8(3):106-111. PubMed ID: 29081617
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan improves vascular function independently of metabolic and antihypertensive effects in hypertensive subjects with impaired glucose tolerance.
Perl S; Schmölzer I; Sourij H; Pressl H; Eder M; Zweiker R; Wascher TC
Int J Cardiol; 2010 Mar; 139(3):289-96. PubMed ID: 19118910
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic treatment with telmisartan induces tissue-specific gene modulation favoring normal glucose homeostasis in Cohen-Rosenthal diabetic hypertensive rats.
Younis F; Oron Y; Limor R; Stern N; Rosenthal T
Metabolism; 2012 Feb; 61(2):164-74. PubMed ID: 21820685
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes.
Suksomboon N; Poolsup N; Prasit T
J Clin Pharm Ther; 2012 Jun; 37(3):319-27. PubMed ID: 21848583
[TBL] [Abstract][Full Text] [Related]
13. Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Ferrari I; Gravina A; Fogari R
Hypertens Res; 2006 Nov; 29(11):849-56. PubMed ID: 17345784
[TBL] [Abstract][Full Text] [Related]
14. Effects of manidipine and its combination with an ACE inhibitor on insulin sensitivity and metabolic, inflammatory and prothrombotic markers in hypertensive patients with metabolic syndrome: the MARCADOR study.
Martinez-Martin FJ; Macias-Batista A; Comi-Diaz C; Rodriguez-Rosas H; Soriano-Perera P; Pedrianes-Martin P
Clin Drug Investig; 2011; 31(3):201-12. PubMed ID: 21155616
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of telmisartan vs. losartan in control of mild-to-moderate hypertension: a multicentre, randomised, double-blind study.
Zhu JR; Bai J; Cai NS; Tang B; Fan WH; Guo JZ; Ke YN; Guo JX; Sheng LH; Lu ZY; Cheng NN
Int J Clin Pract Suppl; 2004 Dec; (145):46-9. PubMed ID: 15617459
[TBL] [Abstract][Full Text] [Related]
16. Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone.
Derosa G; Fogari E; D'Angelo A; Cicero AF; Salvadeo SA; Ragonesi PD; Ferrari I; Gravina A; Fassi R; Fogari R
J Clin Pharm Ther; 2007 Jun; 32(3):261-8. PubMed ID: 17489878
[TBL] [Abstract][Full Text] [Related]
17. Role of insulin-sensitizing property of telmisartan, a commercially available angiotensin II type 1 receptor blocker in preventing the development of atrial fibrillation.
Yamagishi S; Takenaka K; Inoue H
Med Hypotheses; 2006; 66(1):118-20. PubMed ID: 16154710
[TBL] [Abstract][Full Text] [Related]
18. Effects of azilsartan compared with telmisartan on insulin resistance in patients with essential hypertension and type 2 diabetes mellitus: An open-label, randomized clinical trial.
Naruse M; Koike Y; Kamei N; Sakamoto R; Yambe Y; Arimitsu M
PLoS One; 2019; 14(4):e0214727. PubMed ID: 30943275
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.
Benndorf RA; Rudolph T; Appel D; Schwedhelm E; Maas R; Schulze F; Silberhorn E; Böger RH
Metabolism; 2006 Sep; 55(9):1159-64. PubMed ID: 16919533
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of perindopril, enalapril, losartan and telmisartan in overweight or obese patients with hypertension.
Nedogoda SV; Ledyaeva AA; Chumachok EV; Tsoma VV; Mazina G; Salasyuk AS; Barykina IN
Clin Drug Investig; 2013 Aug; 33(8):553-61. PubMed ID: 23800977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
